Back to All Companies

Eli Lilly & Company | Company Profile, Marketing Contacts, Media Spend, Brands




Treating and developing cures for the world's diseases has been Eli Lilly's goal since its establishment in 1876. The company develops and markets pharmaceutical solutions for a variety of diseases affecting humans and animals, including cancer, diabetes, schizophrenia, and ADHD. Lilly's products can be found globally, and research and development of new drugs is handled in over 50 countries.

Main Telephone (317) 276-2000
Main Fax (317) 277-6579
Primary Address
Lilly Corporate Center
Indianapolis, IN 46285
USA

Eli Lilly & Company Contacts

Contacts (5/43)
Name Title State
Enrique C. President, LillyUSA IN
Sample of Associated Brands
***********
Email: *****@*******.***
Main Phone: (317) 276-2000
Direct Phone: *** **** ***   ext: ****
Direct Fax: *** **** ***
Assistant Name: ** **** ***
Assistant Phone: *** **** ***
Address: Lilly Corporate Center
Indianapolis, IN
46285
USA

John L. Chairman, Chief Executive Officer & President IN
John B. Chief Marketing Officer - Lilly USA IN
Derica R. Executive Vice President, Global Services & Chief Financial Officer IN
Karla A. Chief Marketing Officer IN

Media Spend

Media Spend Summary
Media Spend Channel

Associated Brands

Brand Media Spend
Evista ****
Gemzar *
Humalog *******
Humatrope *
Humulin ******

Agency Relationships


Brand Agency Service From To
****** *** media buying & planning unknown present
****** *******-****** creative unknown present
****** *** media buying & planning 2008 present
****** *** media buying & planning unknown present
******** *** media buying & planning unknown present

See Winmo sales intelligence in action

Recent Discussions

Who is the President, LillyUSA of Eli Lilly & Company?

Who is the marketing contact for pharmaceuticals & OTC drugs in IN

What is the email of the Chairman, Chief Executive Officer & President of Eli Lilly & Company?

What is direct phone of the Chief Marketing Officer - Lilly USA of Eli Lilly & Company?

Who is the media buying & planning agency of Eli Lilly & Company?

Your personal LinkedIn network connections

Your personal LinkedIn network connections

DailyVista

Lilly USA ups new President


The Story
Pharmaceutical giant Eli Lilly and Company announced the promotion of Enrique Conterno, currently senior vice president of health care professional markets, to the role of president of Lilly USA, according to the company.
 
Conterno succeeds Deirdre Connelly, who has led the Indianapolis-based company’s operations since 2005. Connelly resigned from the company to pursue other opportunities.
 
Conterno will report directly to Bryce Carmine, executive vice president of global marketing and sales, and will join Lilly USA’s operations committee. He will also retain his role as a member of the senior management council. His new appointment is effective immediately.
 
Lilly USA develops a growing portfolio of medicines and other pharmaceutical products that treat global diseases. The company develops and markets solutions for a variety of ailments that affect both humans and animals, including cancer, diabetes, schizophrenia, and Attention Deficit and Hyperactive Disorder.
 
The Research
Spokesperson Phil Belt told DailyVista that because Lilly USA develops and manufactures such a wide variety of medications, the company has many types of consumers to target.
 
There’s a combination of private payment, which includes individual consumers and insurance companies, as well as health care that’s provided through the government like Medicaid and other similar businesses.
 
“Part of Lilly USA and part of Enrique’s new job is the responsibility for our business-to-business relationships with insurance companies and managed care organizations; our B-to-G, which is government operations, because it’s such an important customer; and our traditional direct-to-consumer advertising for certain medicines,” Belt said. “We’ve also got a sales force in the U.S. that calls on physicians and hospitals, and all of this falls under Lilly USA.”
 
Because Conterno brings such an extensive background in marketing to his new position, from both inside and out of the United States, Belt said that a lot of his direct staff will be Lilly USA corporate marketers that will report up to him. Conterno’s involvement with Lilly USA’s marketing initiatives is a large part of his new responsibilities.
 
“Brand awareness – and by that I don’t mean the corporate brand, but all of the product brands that we actively market today – is certainly at the core of what the ‘brand teams’ do,” Belt said. “In his (Conterno’s) role, he’ll have oversight for not just the operational aspects of the sales force and the B-to-B efforts, but ultimately he’ll oversee development of the brand equity in each brand. Lilly USA is a shade over half of our total business, and for all of the functions within our U.S. business, he now has oversight.”
 
While our source was unsure about some of Lilly USA’s specific agency relationships, he said that partnerships are an important part of the company’s strategy.
 
“We refer to it as a FIPNet – Fully Integrated Pharmaceutical Network – and we use a lot of partners for many things,” he belt said. “To say that we are certainly open to partnerships big and small is entirely accurate.”
 
According to The List database, New York-based Snell Medical Communications has handled Lilly’s public relations since 2006, Chicago-based TBA Global Events has worked on its branding since 2005 and Kansas City, Mo.-based McCormick Company has assisted with its integrated marketing since 1999.
 
The Nielsen Company reported that Lilly spent about $184.2 million on measured media in 2007. About $87.1 million was spent on network television ads, $32.5 million was spent on national magazine ads and about $31.2 million was spent on cable television ads.

Eli Lilly & Company
1555 South Harding Street
Indianapolis, IN 46221
(317) 276-2000
 
Enrique Conterno
President, Lilly USA
(317) 276-2000
 
Bryce Carmine
Executive Vice President, Global Marketing & Sales
(317) 276-2000
 
Dr. John Lechleiter
Chief Executive Officer
(317) 276-2000